Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
4DMT Announces Leadership Expansion with Proven Late-Stage Executives to Drive 4D-150 Execution and BLA Readiness
-
Silence Therapeutics to Participate in September Investor Conferences
-
CalPrivate Bank Appoints Kathy Moe Lonowski to the CalPrivate Bank Board
-
Karbone Research Relaunches as Noreva: AI-Powered Market Intelligence for the Energy Transition
-
Hopebridge Continues to Grow Autism Therapy Services in Founding State of Indiana
-
IRADIMED CORPORATION Announces Board Transition: Anthony Vuoto Retires, Joe Kiani Appointed as New Director
-
KALA BIO Appoints Todd Bazemore as President, Chief Executive Officer and Director
-
Vielight Neuro Technology Gains Traction Across Professional Sports, Powering Champions with Evidence-Backed Results
-
PETVIVO HOLDING, INC. ANNOUNCES DISTRIBUTION AGREEMENT WITH NUPSALA LIMITED
-
Department of Defense (DoD) Awards Nearly $1 Million to Steadman Philippon Research Institute (SPRI) for Breakthrough Study on Extracellular Vesicles Therapeutic for Joint Regeneration
-
Highridge Medical Acquires Innovative Products from Accelus to Expand Capabilities in Spine Surgery
-
PDS Biotech to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
-
Mellow Mushroom powers data-driven marketing and expansion with Bikky
-
Calidi Biotherapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
-
Oxford Lane Capital Corp. Announces Further Detail on its Previously Announced 1-for-5 Reverse Stock Split
-
Lisata Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
-
Camposol Holding PLC reports Preliminary Second Quarter and First Half 2025 Results.
-
Tectonic Metals Announces Virtual Drill Core Shack and Completion of Phase One Drill Program at Flat Gold Project
-
OMass Therapeutics Enters into Exclusive Collaboration and License Agreement with Genentech to Develop and Commercialize Therapies for Inflammatory Bowel Disease
-
Step Pharma announces first participant dosed in a phase 1b clinical trial of dencatistat for essential thrombocythaemia
-
Western Announces New Chief Client Officer
-
Brenmiller Advances Tempo and Wolfson TES Projects Expected to Generate Revenue from bGen Starting 2026
-
Twin Vee Subsidiary Wizz Banger, Inc Launches WizzBanger Value App - AI-Powered Valuations for Buyers, Sellers, Dealers, and Lenders
-
Form 8.3 - AXA INVESTMENT MANAGERS: JTC plc
-
Suzano announces cash tender offers for notes due 2026 and 2027
-
GZA Acquires Assets of Siefert Associates, LLC
-
COCA Unveils COCA 2.0: A Stablecoin Banking App Designed for Real-World Use
-
Coach Ran Biderman, Founder of RB International, Accepted into Forbes Coaches Council
-
Stereotaxis to Present at Upcoming Investor Conferences
-
NURAN WIRELESS Reports Second Quarter 2025 Financial Results
-
Glenmark Pharmaceuticals Inc., USA to launch Eribulin Mesylate Injection, 1mg/2Ml (0.5 mg/mL) Single-Dose Vials
-
New Technology from Ramsey Theory Group Brings Diagnostic Testing and Telehealth Directly into Patients' Homes
-
Kentucky FFA Foundation Announces $11 Million Gift From Bill Gatton Foundation
-
Cizzle Brands Announces CWENCH Hydration™ is Now the Official Sport Drink of the NHL’s Ottawa Senators
-
LICT Corporation Announces Acquisition of Gunnison Telephone Company
-
Kayne Anderson Energy Infrastructure Fund Announces Distribution of $0.08 per Share for September 2025
-
Fundamental Global Inc.’s CEO of Digital Assets, Maja Vujinovic, to Join Anchorage Digital’s Livestream on September 3, 2025
-
Firstsource named Horizon 3 Market Leader in HFS Horizons: The Best Service Providers for Mortgage Reinvention, 2025
-
Intensity Therapeutics, Inc. to Participate in Fireside Chat at the H.C. Wainwright 27th Annual Global Investment Conference
-
Best Vagus Nerve Stimulation Device
-
The Bible is Back: Explosive Documentary Details How Christian Parents Are Reclaiming Education Hours -- and Critics Can't Stand It
-
Inflammatix Data in Journal of Clinical Microbiology Validate Accuracy, Robustness, and Ease of Use of TriVerity™ Test System
-
Magaya and Adelante SCM Publish Future-Focused Preparedness Report: Freight Forwarding at a Crossroads: Preparing for 2026 and Beyond
-
OS Therapies Provides OST-HER2 Recurrent, Fully Resected, Pulmonary Metastatic Osteosarcoma Program Update Following FDA End of Phase 2 Meeting
-
Emergent BioSolutions Awarded $30 Million Contract Modification for CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted), a Two-Dose Anthrax Vaccine for Post-Exposure Prophylaxis Use
-
Form 8.3 - Life Science REIT Plc
-
Form 8.3 - Empiric Student Property Plc
-
TERREPOWER's Solar Brand Ontility to Showcase Sustainable Manufacturing at Scale at RE+, North America's Largest Clean Energy Event
-
Form 8.3 - Apax Global Alpha Limited
-
Dexterra Group Announces Closing of Right Choice Camps & Catering Acquisition
